ENVESTNET ASSET MANAGEMENT INC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 187 filers reported holding PDL BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2020$252,000
-15.4%
89,207
-3.0%
0.00%
Q4 2019$298,000
+79.5%
91,923
+19.8%
0.00%
Q3 2019$166,000
-26.2%
76,716
+7.2%
0.00%
Q2 2019$225,000
-14.8%
71,564
+0.8%
0.00%
Q1 2019$264,000
+26300.0%
70,979
+9982.2%
0.00%
Q2 2018$1,000
-50.0%
7040.0%0.00%
Q1 2018$2,000
+100.0%
704
+245.1%
0.00%
Q4 2017$1,000
-98.0%
204
-98.6%
0.00%
Q3 2017$49,000
+2350.0%
14,283
+1928.8%
0.00%
Q2 2017$2,000704
+245.1%
0.00%
Q1 2017$0
-100.0%
204
-96.4%
0.00%
Q4 2016$11,000
-50.0%
5,617
-16.3%
0.00%
Q3 2016$22,0000.0%6,712
-5.3%
0.00%
Q2 2016$22,000
-53.2%
7,088
-50.0%
0.00%
Q1 2016$47,000
-9.6%
14,184
-3.9%
0.00%
Q4 2015$52,000
-11.9%
14,765
+26.3%
0.00%
Q3 2015$59,000
+1866.7%
11,686
+2496.9%
0.00%
Q4 2014$3,0000.0%4500.0%0.00%
Q3 2014$3,000
-78.6%
450
-67.8%
0.00%
Q2 2014$14,000
+366.7%
1,396
+341.8%
0.00%
Q4 2013$3,0000.0%3160.0%0.00%
Q3 2013$3,000
-57.1%
316
-64.2%
0.00%
Q2 2013$7,0008830.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders